laitimes

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

author:Securities Times
[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

On June 27, the A-share market fell as a whole.

At the close, the Shanghai Composite Index closed at 2,945.85 points, down 0.9%, the Shenzhen Component Index closed at 8,849.7 points, down 1.53%, the ChiNext Index closed at 1,703.2 points, down 1.59%, and the Beijing Stock Exchange 50 Index fell 1.6%. The total turnover of the A-share market was 629.144 billion yuan, a decrease of 17.177 billion yuan from the previous trading day.

1. The net outflow of funds in the A-share market throughout the day was 19.937 billion yuan

Today, the main capital of the A-share market had a net outflow of 5.107 billion yuan at the opening, a net outflow of 4.078 billion yuan at the end of the day, and a net outflow of 19.937 billion yuan in the A-share market throughout the day.

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

2. The CSI 300 has a net outflow of 7.29 billion yuan of main funds today

The CSI 300 had a net outflow of 7.29 billion yuan of main funds today, a net outflow of 6.603 billion yuan from the ChiNext Board, and a net outflow of 558 million yuan from the Science and Technology Innovation Board.

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

3. The net outflow of the pharmaceutical and biological industry was 5.365 billion yuan

Among the primary industries of Shenwan, the net outflow of funds from the pharmaceutical and biological, machinery and equipment, basic chemicals, computers and other industries ranks first, of which the net outflow of the pharmaceutical and biological industry is 5.365 billion yuan.

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

4. The net inflow of the main capital of Lingyi Intelligent Manufacturing was 418 million yuan, ranking first

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

(Note: This table is the net inflow statistics of main funds, which is different from the net buying statistics of institutions in the previous table and the next table)

5. Dragon and Tiger List institutions rushed to raise 10 shares

According to the data of the after-hours Dragon and Tiger List, institutions appeared in 25 shares, of which 10 shares such as Espressif Technology were net bought by institutional funds, and 15 shares such as Hisense Home Appliances were net sold by institutional funds.

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

6. Institutions pay attention to the latest individual stocks

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

Editor-in-charge: Ye Shuyun

Proofreading: Yang Lilin

Copyright Notice

All original content on the platforms of the Securities Times shall not be reproduced by any unit or individual without written authorization. Our company reserves the right to pursue the legal responsibility of relevant actors.

转载与合作可联系证券时报小助理,微信ID:SecuritiesTimes

END
[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares

Click on a keyword to view it

Periscope Series In-depth Report丨Stock Council Column丨Investment in Xiaohongshu丨E Company Investigation丨Times Meeting Room丨Top Ten Celebrity Private Equity Interview丨Former Defense Ministers Wei Fenghe and Li Shangfu were expelled from the party! 丨A shares are "killing pigs" again? The 6-minute flash crash is set! The Shenzhen-Zhongshan Passage was officially opened on June 30 丨Suddenly! There was a military coup in Bolivia, and tanks broke into the presidential palace丨 latest! The "$2 trillion market value club" welcomes new members丨Evergrande Automobile, late-night announcement丨The National Standing Committee will be heavy! Take multiple measures to stabilize foreign investment丨Heavy! Beijing property market: down payment, interest rate lowered! 丨It's about venture capital! The National Development and Reform Commission, the China Securities Regulatory Commission and other four departments speak out in unison!

[27th capital roadmap] the pharmaceutical and biological sector has a net outflow of more than 5.3 billion yuan, ranking first, and institutions on the Dragon and Tiger List are rushing to raise many shares